# Evaluation of National Immunization Technical Advisory Groups (NITAGs) of middle-income countries in the WHO European Region; a synopsis

**Authors:** Wiebe Külper-Schiek, Liudmila Mosina, Lisa A. Jacques-Carroll, Annika Falman, Thomas Harder, Eduard Kakarriqi, Iria Preza, Arman Badalyan, Gayane Sahakyan, Oxana Romanova, Veronika Shimanovich, Sanjin Musa, Dinagul Bayesheva, Nurshay Azimbayeva, Zuridin Nurmatov, Vera Toigombaeva, Ninel Revenco, Veaceslav Gutu, Ljiljana Markovic-Denic, Branka Bonaci-Nikolic, Dilorom Tursunova, Nigora Tadzhiyeva, Ole Wichmann, Siddhartha Sankar Datta

PMC · DOI: 10.3389/fpubh.2025.1464370 · Frontiers in Public Health · 2025-02-19

## TL;DR

This paper evaluates how well national immunization advisory groups in middle-income countries of the WHO European Region are functioning and identifies key challenges and improvements.

## Contribution

The study provides a comprehensive evaluation of NITAGs in middle-income countries and outlines strategies for improving their functionality.

## Key findings

- 58% of NITAGs and 66% of those in middle-income countries met all six WHO process indicators of functionality.
- The main challenge for NITAGs is the lack of a well-staffed Secretariat to support their operations.
- Improvement plans have been developed and implemented to address identified challenges.

## Abstract

A National Immunization Technical Advisory Group (NITAG) provides independent guidance to Ministries of Health (MoH) and policymakers, enabling them to make informed decisions on national immunization policies and practices. As of 2022, 50 of the 53 countries in the World Health Organization (WHO) European Region (the Region) had established a NITAG, with 58% of all NITAGs and 66% of those in middle-income countries (MICs) in the Region meeting all six WHO process indicators of NITAG functionality. However, many newly established NITAGs in MICs in the Region experience challenges in terms of their functioning, structure, and outputs.

To address these challenges and achieve the goal of evidence-informed decision making on immunizations, the WHO Regional Office for Europe and the Robert Koch Institute (RKI) implemented a project to strengthen the functioning of MIC NITAGs of the Region through comprehensive evaluations of nine NITAGs and development and implementation of improvement plans.

All evaluated NITAGs are formally established and complete the most important aspects of NITAG functioning. The main challenge for all NITAGs is the lack of a well-staffed Secretariat to establish annual workplans and develop NITAG recommendations following a standardized process.

The evaluation identified NITAGs' strengths and challenges. Some challenges have been addressed through improvement plan implementation. WHO and RKI will continue to evaluate NITAGs and support development and implementation of improvement plans. WHO and NITAG partners will continue to provide training on the standardized recommendation-making process and advocate increased MoH support to NITAGs, including dedicated Secretariat staff.

## Full-text entities

- **Diseases:** infectious diseases (MESH:D003141), COVID-19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human papillomavirus (species) [taxon 10566]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11881447/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC11881447/full.md

---
Source: https://tomesphere.com/paper/PMC11881447